The University of Southampton
University of Southampton Institutional Repository

IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia

IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia
IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia
Background: Prognostic index for survival estimation by clinical-demographic variables were previously proposed in chronic lymphocytic leukemia (CLL) patients. Our objective was to test in a large retrospective cohort of CLL patients the prognostic power of biological and clinical-demographic variable in a comprehensive multivariate model. A new prognostic index was proposed.

Methods: Overall survival and time to treatment in 620 untreated CLL patients were analyzed retrospectively to evaluate the multivariate independence and predictive power of mutational status of immunoglobulin heavy chain variable gene segments (IGHV), high-risk chromosomal aberration such as 17p or 11q deletions, CD38 and ZAP-70 expression, age, gender, Binet stage, ?2-microglobulin levels, absolute lymphocyte count and number of lymph node regions.

Results: IGHV mutational status and 17p deletion were the sole biological variables with independent prognostic relevance in a multivariate model for overall survival, which included easily measurable clinical parameters (Binet staging, ?2-microglobulin levels) and demographics (age and gender). Analysis of time to treatment in Binet A patients below 70 years of age showed that IGHV was the most important predictor. A novel 6-variable clinical-biological prognostic index was developed and internally validated, which assigned 3 points for Binet C stage, 2 points/each for Binet B stage and for age > 65 years, 1 point/each for male gender, high ?2-microglobulin levels, presence of an unmutated IGHV gene status or 17p deletion. Patients were classified at low-risk (score = 0-1; 21%), intermediate-risk (score 2-5; 63% of cases), high-risk (score 6-9; 16% of cases). Projected 5-year overall survival was 98%, 90% and 58% in low-, intermediate- and high-risk groups, respectively. A nomogram for individual patient survival estimation was also proposed.

Conclusions: Data indicate that IGHV mutational status and 17p deletion may be integrated with clinical-demographic variables in new prognostic tools to estimate overall survival.
chronic lymphocytic leukaemia, prognosis, prognostic score, nomogram
1479-5876
18
Bulian, Pietro
aa3b2489-d243-4e84-bcf5-fcd698f5f4ce
Rossi, Davide
b4b2506d-794c-4c79-8b2d-6767554fd52a
Forconi, Francesco
ba40e5ec-24ea-48d5-9a69-c0ffedaf8894
Del Poeta, Giovanni
ed2857f8-ebfc-4d88-96cd-21423e57738d
Bertoni, Francesco
13297a2f-854a-4841-a410-d6bfca8afee8
Zucca, Emanuele
40bd5950-d74e-4169-a2ea-0bfc1058058e
Montillo, Marco
691d7981-7b83-4b59-a653-e796c208a07c
Pozzato, Gabriele
1c9c6230-d4bd-42b7-915a-5168cd09d2d4
D'Arena, Giovanni
70024606-1ca7-4d41-ba16-1332478923a3
Efremov, Dimitar G
61782004-86fe-45a4-8960-0871e7cdd6f4
Marasca, Roberto
918148d0-8f99-4a29-8322-1b34f6d7dd00
Lauria, Francesco
f01f163b-abcb-4aad-b952-f4356692f519
Gaidano, Gianluca
1a6a7107-107b-4891-82e0-5fedadd2f65a
Gattei, Valter
df828ae8-1b40-4acb-8908-5a6b3d16cf99
Laurenti, Luca
23c6052d-80af-4fac-92da-2a495a8cb440
Bulian, Pietro
aa3b2489-d243-4e84-bcf5-fcd698f5f4ce
Rossi, Davide
b4b2506d-794c-4c79-8b2d-6767554fd52a
Forconi, Francesco
ba40e5ec-24ea-48d5-9a69-c0ffedaf8894
Del Poeta, Giovanni
ed2857f8-ebfc-4d88-96cd-21423e57738d
Bertoni, Francesco
13297a2f-854a-4841-a410-d6bfca8afee8
Zucca, Emanuele
40bd5950-d74e-4169-a2ea-0bfc1058058e
Montillo, Marco
691d7981-7b83-4b59-a653-e796c208a07c
Pozzato, Gabriele
1c9c6230-d4bd-42b7-915a-5168cd09d2d4
D'Arena, Giovanni
70024606-1ca7-4d41-ba16-1332478923a3
Efremov, Dimitar G
61782004-86fe-45a4-8960-0871e7cdd6f4
Marasca, Roberto
918148d0-8f99-4a29-8322-1b34f6d7dd00
Lauria, Francesco
f01f163b-abcb-4aad-b952-f4356692f519
Gaidano, Gianluca
1a6a7107-107b-4891-82e0-5fedadd2f65a
Gattei, Valter
df828ae8-1b40-4acb-8908-5a6b3d16cf99
Laurenti, Luca
23c6052d-80af-4fac-92da-2a495a8cb440

Bulian, Pietro, Rossi, Davide, Forconi, Francesco, Del Poeta, Giovanni, Bertoni, Francesco, Zucca, Emanuele, Montillo, Marco, Pozzato, Gabriele, D'Arena, Giovanni, Efremov, Dimitar G, Marasca, Roberto, Lauria, Francesco, Gaidano, Gianluca, Gattei, Valter and Laurenti, Luca (2012) IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia. Journal of Translational Medicine, 10, 18. (doi:10.1186/1479-5876-10-18). (PMID:22289136)

Record type: Article

Abstract

Background: Prognostic index for survival estimation by clinical-demographic variables were previously proposed in chronic lymphocytic leukemia (CLL) patients. Our objective was to test in a large retrospective cohort of CLL patients the prognostic power of biological and clinical-demographic variable in a comprehensive multivariate model. A new prognostic index was proposed.

Methods: Overall survival and time to treatment in 620 untreated CLL patients were analyzed retrospectively to evaluate the multivariate independence and predictive power of mutational status of immunoglobulin heavy chain variable gene segments (IGHV), high-risk chromosomal aberration such as 17p or 11q deletions, CD38 and ZAP-70 expression, age, gender, Binet stage, ?2-microglobulin levels, absolute lymphocyte count and number of lymph node regions.

Results: IGHV mutational status and 17p deletion were the sole biological variables with independent prognostic relevance in a multivariate model for overall survival, which included easily measurable clinical parameters (Binet staging, ?2-microglobulin levels) and demographics (age and gender). Analysis of time to treatment in Binet A patients below 70 years of age showed that IGHV was the most important predictor. A novel 6-variable clinical-biological prognostic index was developed and internally validated, which assigned 3 points for Binet C stage, 2 points/each for Binet B stage and for age > 65 years, 1 point/each for male gender, high ?2-microglobulin levels, presence of an unmutated IGHV gene status or 17p deletion. Patients were classified at low-risk (score = 0-1; 21%), intermediate-risk (score 2-5; 63% of cases), high-risk (score 6-9; 16% of cases). Projected 5-year overall survival was 98%, 90% and 58% in low-, intermediate- and high-risk groups, respectively. A nomogram for individual patient survival estimation was also proposed.

Conclusions: Data indicate that IGHV mutational status and 17p deletion may be integrated with clinical-demographic variables in new prognostic tools to estimate overall survival.

This record has no associated files available for download.

More information

Published date: 30 January 2012
Additional Information: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: chronic lymphocytic leukaemia, prognosis, prognostic score, nomogram
Organisations: Cancer Sciences

Identifiers

Local EPrints ID: 358114
URI: http://eprints.soton.ac.uk/id/eprint/358114
ISSN: 1479-5876
PURE UUID: 2fbbb69c-017c-44fb-9a11-825a9e99236b

Catalogue record

Date deposited: 04 Oct 2013 11:17
Last modified: 14 Mar 2024 15:00

Export record

Altmetrics

Contributors

Author: Pietro Bulian
Author: Davide Rossi
Author: Francesco Forconi
Author: Giovanni Del Poeta
Author: Francesco Bertoni
Author: Emanuele Zucca
Author: Marco Montillo
Author: Gabriele Pozzato
Author: Giovanni D'Arena
Author: Dimitar G Efremov
Author: Roberto Marasca
Author: Francesco Lauria
Author: Gianluca Gaidano
Author: Valter Gattei
Author: Luca Laurenti

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×